150 related articles for article (PubMed ID: 37747071)
1. An overview of novel antimicrobial carbonic anhydrase inhibitors.
Supuran CT
Expert Opin Ther Targets; 2023; 27(10):897-910. PubMed ID: 37747071
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of bacterial carbonic anhydrases and zinc proteases: from orphan targets to innovative new antibiotic drugs.
Supuran CT
Curr Med Chem; 2012; 19(6):831-44. PubMed ID: 22214451
[TBL] [Abstract][Full Text] [Related]
3. Biochemical characterization of recombinant β-carbonic anhydrase (PgiCAb) identified in the genome of the oral pathogenic bacterium Porphyromonas gingivalis.
Del Prete S; Vullo D; De Luca V; AlOthman Z; Osman SM; Supuran CT; Capasso C
J Enzyme Inhib Med Chem; 2015 Jun; 30(3):366-70. PubMed ID: 25032746
[TBL] [Abstract][Full Text] [Related]
4. Bacterial, fungal and protozoan carbonic anhydrases as drug targets.
Capasso C; Supuran CT
Expert Opin Ther Targets; 2015; 19(12):1689-704. PubMed ID: 26235676
[TBL] [Abstract][Full Text] [Related]
5. May Sulfonamide Inhibitors of Carbonic Anhydrases from
De Luca V; Giovannuzzi S; Supuran CT; Capasso C
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430304
[No Abstract] [Full Text] [Related]
6. Carbonic anhydrase and bacterial metabolism: a chance for antibacterial drug discovery.
Capasso C; Supuran CT
Expert Opin Ther Pat; 2024 Jun; 34(6):465-474. PubMed ID: 38506448
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of bacterial α-, β- and γ-class carbonic anhydrases with selenazoles incorporating benzenesulfonamide moieties.
Angeli A; Pinteala M; Maier SS; Del Prete S; Capasso C; Simionescu BC; Supuran CT
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):244-249. PubMed ID: 30734601
[TBL] [Abstract][Full Text] [Related]
8. Development of Penicillin-Based Carbonic Anhydrase Inhibitors Targeting Multidrug-Resistant
Bonardi A; Nocentini A; Giovannuzzi S; Paoletti N; Ammara A; Bua S; Abutaleb NS; Abdelsattar AS; Capasso C; Gratteri P; Flaherty DP; Seleem MN; Supuran CT
J Med Chem; 2024 Jun; 67(11):9613-9627. PubMed ID: 38776401
[TBL] [Abstract][Full Text] [Related]
9. Bacterial ι-carbonic anhydrase: a new active class of carbonic anhydrase identified in the genome of the Gram-negative bacterium
Del Prete S; Nocentini A; Supuran CT; Capasso C
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1060-1068. PubMed ID: 32314608
[TBL] [Abstract][Full Text] [Related]
10. Inhibition studies of the β-carbonic anhydrases from the bacterial pathogen Salmonella enterica serovar Typhimurium with sulfonamides and sulfamates.
Nishimori I; Minakuchi T; Vullo D; Scozzafava A; Supuran CT
Bioorg Med Chem; 2011 Aug; 19(16):5023-30. PubMed ID: 21757360
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Thio- and Seleno-Acetamides Bearing Benzenesulfonamide as Inhibitor of Carbonic Anhydrases from Different Pathogenic Bacteria.
Angeli A; Pinteala M; Maier SS; Simionescu BC; Milaneschi A; Abbas G; Del Prete S; Capasso C; Capperucci A; Tanini D; Carta F; Supuran CT
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963423
[TBL] [Abstract][Full Text] [Related]
12. Carbonic anhydrase inhibitors: cloning and sulfonamide inhibition studies of a carboxyterminal truncated alpha-carbonic anhydrase from Helicobacter pylori.
Nishimori I; Vullo D; Minakuchi T; Morimoto K; Onishi S; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2006 Apr; 16(8):2182-8. PubMed ID: 16459077
[TBL] [Abstract][Full Text] [Related]
13. Carbonic anhydrase inhibitors. Inhibition of the Rv1284 and Rv3273 beta-carbonic anhydrases from Mycobacterium tuberculosis with diazenylbenzenesulfonamides.
Maresca A; Carta F; Vullo D; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2009 Sep; 19(17):4929-32. PubMed ID: 19651511
[TBL] [Abstract][Full Text] [Related]
14. Sulfonamide inhibition study of the β-class carbonic anhydrase from the caries producing pathogen Streptococcus mutans.
Dedeoglu N; DeLuca V; Isik S; Yildirim H; Kockar F; Capasso C; Supuran CT
Bioorg Med Chem Lett; 2015 Jun; 25(11):2291-7. PubMed ID: 25913199
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the sulfonamide inhibition profiles of the α-, β- and γ-carbonic anhydrases from the pathogenic bacterium Vibrio cholerae.
Del Prete S; Vullo D; De Luca V; Carginale V; Osman SM; AlOthman Z; Supuran CT; Capasso C
Bioorg Med Chem Lett; 2016 Apr; 26(8):1941-6. PubMed ID: 26972117
[TBL] [Abstract][Full Text] [Related]
16. Sulfonamide inhibition profiles of the β-carbonic anhydrase from the pathogenic bacterium Francisella tularensis responsible of the febrile illness tularemia.
Del Prete S; Vullo D; Osman SM; AlOthman Z; Supuran CT; Capasso C
Bioorg Med Chem; 2017 Jul; 25(13):3555-3561. PubMed ID: 28511911
[TBL] [Abstract][Full Text] [Related]
17. Sulfonamide inhibition studies of two β-carbonic anhydrases from the bacterial pathogen Legionella pneumophila.
Nishimori I; Vullo D; Minakuchi T; Scozzafava A; Capasso C; Supuran CT
Bioorg Med Chem; 2014 Jun; 22(11):2939-46. PubMed ID: 24792813
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of sulfonamides with effective inhibitory action against Porphyromonas gingivalis γ-carbonic anhydrase.
Ceruso M; Del Prete S; AlOthman Z; Osman SM; Scozzafava A; Capasso C; Supuran CT
Bioorg Med Chem Lett; 2014 Aug; 24(16):4006-10. PubMed ID: 25011913
[TBL] [Abstract][Full Text] [Related]
19. Bacterial carbonic anhydrases as drug targets: toward novel antibiotics?
Supuran CT
Front Pharmacol; 2011; 2():34. PubMed ID: 21779249
[TBL] [Abstract][Full Text] [Related]
20. Structural Basis for the Inhibition of Helicobacter pylori α-Carbonic Anhydrase by Sulfonamides.
Modak JK; Liu YC; Machuca MA; Supuran CT; Roujeinikova A
PLoS One; 2015; 10(5):e0127149. PubMed ID: 26010545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
